KJ ReportsKJ Reports

Bangladesh exports medicines to 127 countries

6 June 2017710

Listen to this article

KJ narrates this report in his own voice

Bangladesh exports medicines to 127 countries

Read original article on abnews24 or read some of the key points below;

  1. Bangladesh’s burgeoning drug industry, after meeting local demand, is exporting drugs and raw materials to 127 countries, the health minister has said.
  2. Mohammed Nasim, replying to questions tabled at the Parliament by MPs on Tuesday, said 98 percent of the Bangladesh’s local demand is being met by Bangladesh’s own pharmaceutical companies.
  3. As a Least Developed Country (LDC), Bangladesh is able to make generic drugs without any intellectual property rights conflicts until 2033. The export earning, around Tk 4 billion, has been increased in recent years with the penetration of costly, regulated markets of the United States and in the Europe.
  4. Replying to a question of MP Israfil Alam, the health minister said, currently 851 factories are functioning in Bangladesh for the production of medicines. Of them, 266 are producing allopathic drugs, 26 are producing Unani medicine, 207 Ayurvedic, 79 homeopathic and 32 herbal medicines.
  5. The health minister, replying the question from MP Lutfa Taher, said the government had suspended licenses of 86 manufacturers temporarily while 19 other have been suspended permanently for violating the Good Manufacturing Practice (GMP) guidelines
#bangladesh#bangladesh-drug-industry#drug-factory#drug-industry#drugs#gmp#pharmaceutical#pharmaceutical-companies

Related Intelligence

More articles
The Dhaka Disconnect: New Delhi’s Neighbourhood Policy Collapse
South Asia

The Dhaka Disconnect: New Delhi’s Neighbourhood Policy Collapse

India’s strategic reliance on a single political dynasty in Bangladesh has backfired. As Dhaka pivots toward Beijing and Islamabad, New Delhi faces a structural security dilemma that threatens its entire eastern flank.

18 Aug 2026

The Tarapur Squeeze: India’s Strategic Pivot to American Atoms
South Asia

The Tarapur Squeeze: India’s Strategic Pivot to American Atoms

As Washington intensifies sanctions on Iranian hydrocarbons, New Delhi is trading its traditional stance of strategic autonomy for long-term energy immunity. This shift marks a fundamental realignment of Indian power around American nuclear technology and logistics.

14 Aug 2026

The India Exception: Why Washington Subsidises New Delhi’s Neutrality
South Asia

The India Exception: Why Washington Subsidises New Delhi’s Neutrality

Despite intensifying Western sanctions on global energy markets, Washington continues to grant New Delhi quiet exemptions. This calculated leniency reveals a structural necessity: the White House cannot counter Beijing without an Indian economy powered by Russian fuel.

14 Aug 2026

The Petrol Rouble: How India’s Refineries Became Russia’s Life Support
South Asia

The Petrol Rouble: How India’s Refineries Became Russia’s Life Support

India’s strategic refusal to join Western price caps has evolved from opportunistic trade into a structural necessity for the Kremlin. Without New Delhi’s refining capacity, the Russian state budget faces immediate fiscal collapse.

13 Aug 2026

The Kilo-Class Pivot: Russia’s Naval Return to the Indian Ocean
South Asia

The Kilo-Class Pivot: Russia’s Naval Return to the Indian Ocean

Moscow is deepening naval integration with India and the Horn of Africa, altering the maritime balance. This shift moves beyond arms sales to structural dependency, challenging Western primacy and reshaping South Asian deterrence.

4 Aug 2026

The Pashtun Pincer: Why the Taliban Must Destabilise the Durand Line
South Asia

The Pashtun Pincer: Why the Taliban Must Destabilise the Durand Line

The Taliban’s survival depends on maintaining domestic legitimacy through a radical Pashtun identity. By challenging the Durand Line, Kabul forces Islamabad into a strategic trap, turning a colonial border into a lever for regime survival and regional leverage.

31 Jul 2026